Funder
Teva Pharmaceutical Industries Ltd.
Reference41 articles.
1. “Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review,”;Ramirez;Gynecol. Oncol.,2004
2. Predictive modes of action of pesticides in uterine adenocarcinoma development in rats;Yoshida;J. Toxicol. Pathol.,2015
3. “Expression of oestrogen receptors, ERα, ERβ, and ERβ variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERα,”;Collins;BMC Cancer,2009
4. “Endometrial cancer and estrogen use — report of a large case-control study,”;Antunes;N. Engl. J. Med.,1979
5. Menopausal hormone therapy and risk of endometrial Cancer,”;Brinton;J. Steroid Biochem. Mol. Biol.,2014
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献